Contact
Our Approach
Our Lab
Who We Serve
About
Team
Resources
Our Approach
Our Lab
Who We Serve
About
Team
Resources
Press Release
Back to Resources
04/02/2024 | Press Release
UCLA and PreciseDx Announce New Collaboration to Advance AI-Enabled Predictions and Risk Mitigation for Triple-Negative Breast Cancer Recurrence
Read More
03/22/2024 | Press Release
PreciseDx Presents New Research on Their AI-Enabled Digital Test at 14th Annual European Breast Conference
Read More
12/22/2023 | Press Release
PreciseDx Collaborates with Baylor Scott & White Health to Validate PreciseBreast™ Assessment for Early-Stage Invasive Breast Cancer Detection
Read More
06/27/2023 | Press Release | PR Newswire
PreciseDx Announces Ted Diehl as Vice President of Commercial Development
Read More
03/08/2023 | Press Release | PR Newswire
PreciseDx to Present on AI-enabled Breast Cancer Grade and Phenotyping Assay at United States and Canadian Academy of Pathology (USCAP) Annual Meeting
Read More
02/21/2023 | Press Release | PR Newswire
PreciseDx Appoints Bradley Gendell as Chief Financial Officer
Read More
02/07/2023 | Press Release | PR Newswire
PreciseDx Receives New York State Approval for an AI-Enabled Breast Diagnostic
Read More
01/31/2023 | Press Release | PR Newswire
PreciseDx Appoints Paul Roma as Chairman of the Board
Read More
01/19/2023 | Press Release | PR Newswire
PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard
Read More
12/13/2022 | Press Release
PreciseDx to Collaborate with the Champalimaud Foundation to Enhance Current Approaches of Breast Cancer Risk Assessment
Read More
1
2
NEXT >